Anscher 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Anscher MS, Chen L, Rabbani Z et al. Recent progress in defining mech- anisms and potential targets for prevention of normal tissue injury after radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:255–259. Laiho M, Keski-Oja J. Transforming growth factors-beta as regulators of cellular growth and phenotype. Crit Rev Oncog 1992;3:1–26. Massagué J, Cheifetz S, Laiho M et al. Transforming growth factor-beta. Cancer Surv 1992;12:81–103. Massagué J, Blain SW, Lo RS. TGF signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295–309. Lamouille S, Derynck R. Cell size and invasion in TGF- -induced epi- thelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007;178:437– 451. Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF- family proteins in development and disease. Nat Cell Biol 2007;9:1000 – 1004. Massagué J. TGF in Cancer. Cell 2008;134:215–230. Taylor IW, Wrana JL. SnapShot: The TGF pathway interactome. Cell 2008;133:378.e1. Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J Clin Oncol 2005;23:2078 –2093. Chen C, Wang XF, Sun L. Expression of transforming growth factor beta (TGF ) type III receptor restores autocrine TGF 1 activity in human breast cancer MCF-7 cells. J Biol Chem 1997;272:12862–12867. Grady WM, Myeroff LL, Swinler SE et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999;59:320 –324. Villanueva A, Garcia C, Paules AB et al. Disruption of the antiprolifera- tive TGF- signaling pathways in human pancreatic cancer cells. Onco- gene 1998;17:1969 –1978. Yan Z, Deng X, Friedman E. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth fac- tor-beta receptor III. J Biol Chem 2001;276:1555–1563. Derynck R, Akhurst RJ, Balmain A. TGF- signaling in tumor suppres- sion and cancer progression. Nat Genet 2001;29:117–129. Branton MH, Kopp JB. TGF- and fibrosis. Microbes Infect 1999;1: 1349 –1365. Border WA, Brees D, Noble NA. Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 1994;107: 140 –145. Munger J, Huang X, Kawakatsu H et al. The integrin vß6 binds and ac- tivates latent TGF 1: A mechanism for regulating pulmonary inflamma- tion and fibrosis. Cell 1999;96:319 –328. Lawrence D. Identification and activation of latent transforming growth factor . Methods Enzymol 1991;198:327–336. Koli K, Saharinen J, Hyytiäinen M et al. Latency, activation, and binding proteins of TGF- . Microsc Res Tech 2001;52:354 –362. Godár S, Horejsi V, Weidle UH et al. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-ß1. Eur J Immunol 1999;29:1004 –1013. Blakytny R, Ludlow A, Martin GE et al. Latent TGF- 1 activation by platelets. J Cell Physiol 2004;199:67–76. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent trans- forming growth factor- 1. Mol Endocrinol 1996;10:1077–1083. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGF activa- tion. J Cell Sci 2003;116:217–224. www.TheOncologist.com 32 33 34 35 36 37 38 39 40 41 43 44 45 46 47 48 49 50 357 Ashcroft GS. Bidirectional regulation of macrophage function by TGF- . Microbes Infect 1999;1:1275–1282. Boyd F, Massagué J. Transforming growth factor- inhibition of epithe- lial cell proliferation linked to the expression of a 53-kDa membrane re- ceptor. J Biol Chem 1989;264:2272–2278. Hakenjos L, Bamberg M, Rodemann H. TGF-ß1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 2000;76:503–509. Fajardo LF, Prionas SD, Kwan HH et al. Transforming growth factor 1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996; 74:600 – 608. Phillips GD, Whitehead RA, Stone AM et al. Transforming growth factor beta (TGF-B) stimulation of angiogenesis: An electron microscopic study. J Submicroscop Cytol Pathol 1993;25:149 –155. Roberts AB, McCune BK, Sporn MB. TGF regulation of extracellular matrix. Kidney Int 1992;41:557–559. Peters H, Border WA, Noble NA. Targeting TGF- overexpression in re- nal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 1998;54:1570 –1580. Border WA, Ruoslahti E. Transforming growth factor-ß in disease: The dark side of tissue repair. J Clin Invest 1992;90:1–7. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125:754 –765. Anscher MS, Kong FM, Jirtle RL. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 1998;19:109 –120. 42 Isaka Y, Brees DK, Ikegaya K et al. Gene therapy by skeletal muscle ex- pression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2:418 – 423. Akagi Y, Isaka Y, Arai M et al. Inhibition of TGF- 1 expression by an- tisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148 –155. Tsushima H, Kawata S, Tamura S et al. Reduced plasma transforming growth factor-ß1 levels in patients with chronic hepatitis C after interfer- on- therapy: Association with regression of hepatic fibrosis. J Hepatol 1999;30:1–7. Border W, Okuda S, Languino LR et al. Suppression of experimental glo- merulonephritis by antiserum against transforming growth factor beta 1. Nature 1990;346:371–374. Rabbani ZN, Batinic-Haberle I, Anscher MS et al. Long-term administra- tion of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys 2007;67:573–580. Rabbani ZN, Anscher MS, Zhang X et al. Soluble TGF type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. Int J Radiat Oncol Biol Phys 2003;57:563–572. Rabbani ZN, Anscher MS, Golson ML et al. Overexpression of extracel- lular superoxide dismutase reduces severity of radiation-induced lung tox- icity through downregulation of the TGF- signal transduction pathway. Int J Radiat Oncol Biol Phys 2003;57:S158 –S159. Nishioka A, Ogawa Y, Mima T et al. Histopathologic amelioration of fi- broproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF- ) receptor mediated by adenoviral vector. Int J Radiat Oncol Biol Phys 2004;58:1235–1241. Nakao A, Fujii M, Matsumura R et al. Transient gene transfer and expres- sion of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999;104:5–11.